Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.43 |
| ▸ | LPL | P06858 | 7/20 | 0.43 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26050385 | 0.89 | LIPG (0.54) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL17143469 | 0.86 | LIPG (0.57) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL17143472 | 0.86 | LIPG (0.57) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL24257896 | 0.86 | LIPG (0.57) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL24257893 | 0.84 | PDK2 (0.40) | — | |
| SCHEMBL12781960 | 0.82 | LIPG (0.62) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL13414973 | 0.80 | LIPG (0.63) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL12781939 | 0.80 | LIPG (0.59) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL24626597 | 0.79 | LIPG (0.57) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL17143221 | 0.79 | LIPG (0.59) | LIPGLPLDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230271989-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-08-31 | — | — | US | disclosed |
| US-20230271989-A1 | METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230271989-A1 | METAL COMPLEXES | AP3M1, AP1M1, AP2M1 | LIPG 3694/4885LPL 3235/4885DGAT1 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.